TCF7L2-rs7903146 polymorphism modulates the effect of artichoke leaf extract supplementation on insulin resistance in metabolic syndrome: a randomized, double-blind, placebo-controlled trial

Journal of Integrative Medicine

Volumn 16, Issue 5, 2018, Pages 329-334

  Ebrahimi Mameghani, Mehranghiz ^a   Asghari Jafarabadi, Mohammad ^b   Rezazadeh, Khatereh ^a,b  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Alternative and complementary medicine; Artichoke leaf extract; Diabetes; Insulin; Insulin resistance; Metabolic syndrome; Transcription factor 7 like 2

Indexed keywords

ANTIDIABETIC AGENT; ARTICHOKE LEAF EXTRACT; GLUCOSE; PLACEBO; PLANT EXTRACT; TRANSCRIPTION FACTOR 7 LIKE 2; UNCLASSIFIED DRUG; INSULIN;

ADULT; ARTICHOKE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; FEMALE; GENOTYPE; HIP CIRCUMFERENCE; HOMEOSTASIS MODEL ASSESSMENT; HUMAN; INSULIN LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; METABOLIC SYNDROME X; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE NUCLEOTIDE POLYMORPHISM; SUPPLEMENTATION; WAIST CIRCUMFERENCE; WAIST HIP RATIO; BLOOD; DIETARY SUPPLEMENT; GENETICS; GLUCOSE BLOOD LEVEL; METABOLISM; MIDDLE AGED; PHYTOTHERAPY;

ADULT; BLOOD GLUCOSE; CYNARA SCOLYMUS; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; GENOTYPE; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME; MIDDLE AGED; PHYTOTHERAPY; PLANT EXTRACTS; POLYMORPHISM, SINGLE NUCLEOTIDE; TRANSCRIPTION FACTOR 7-LIKE 2 PROTEIN;

EID: 85052972224     PISSN: 20954964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joim.2018.05.006     Document Type: Article

References (46)

1. Eckel, R.H., Alberti, K.G., Grundy, S.M., Zimmet, P.Z., The metabolic syndrome. Lancet 375:9710 (2010), 181–183.
2. Suzuki, T., Zeng, Z., Zhao, B., Wei, Z., Tanabe, M., Shimbo, T., et al. Comparison of coronary heart disease risk among four diagnostic definitions of metabolic syndrome. J Endocrinol Inves 39:11 (2016), 1337–1346.
3. Warodomwichit, D., Arnett, D.K., Kabagambe, E.K., Tsai, M.Y., Hixson, J.E., Straka, R.J., et al. Polyunsaturated fatty acids modulate the effect of TCF7L2 gene variants on postprandial lipemia. J Nutr 139:3 (2009), 439–446.
4. Marzi, C., Huth, C., Kolz, M., Grallert, H., Meisinger, C., Wichmann, H.E., et al. Variants of the transcription factor 7-like 2 gene (TCF7L2) are strongly associated with type 2 diabetes but not with the metabolic syndrome in the MONICA/KORA surveys. Horm Metab Res 39:1 (2007), 46–52.
5. Melzer, D., Murray, A., Hurst, A.J., Weedon, M.N., Bandinelli, S., Corsi, A.M., et al. Effects of the diabetes linked TCF7L2 polymorphism in a representative older population. BMC Med, 4(1), 2006, 34.
6. Cropano, C., Santoro, N., Groop, L., Dalla Man, C., Cobelli, C., Galderisi, A., et al. The rs7903146 variant in the TCF7L2 gene increases the risk of prediabetes/type 2 diabetes in obese adolescents by impairing β-cell function and hepatic insulin sensitivity. Diabetes Care 40:8 (2017), 1082–1089.
7. Shah, M., Varghese, R.T., Miles, J.M., Piccinini, F., Dalla Man, C., Cobelli, C., et al. TCF7L2 genotype and α-cell function in humans without diabetes. Diabetes 65:2 (2016), 371–380.
8. Yi, F., Brubaker, P.L., Jin, T., TCF-4 mediates cell type-specific regulation of proglucagon gene expression by β-catenin and glycogen synthase kinase-3β. J Biol Chem 280:2 (2005), 1457–1464.
9. Zimdahl, H., Ittrich, C., Graefe-Mody, U., Boehm, B.O., Mark, M., Woerle, H.J., et al. Influence of TCF7L2 gene variants on the therapeutic response to the dipeptidylpeptidase-4 inhibitor linagliptin. Diabetologia 57:9 (2014), 1869–1875.
10. Mattei, J., Qi, Q., Hu, F.B., Sacks, F.M., Qi, L., TCF7L2 genetic variants modulate the effect of dietary fat intake on changes in body composition during a weight-loss intervention. Am J Clin Nutr 96:5 (2012), 1129–1136.
11. Ben Salem, M., Affes, H., Ksouda, K., Dhouibi, R., Sahnoun, Z., Hammami, S., et al. Pharmacological studies of artichoke leaf extract and their health benefits. Plant Foods Hum Nutr 70:4 (2015), 441–453.
12. Wittemer, S.M., Ploch, M., Windeck, T., Müller, S.C., Drewelow, B., Derendorf, H., et al. Bioavailability and pharmacokinetics of caffeoylquinic acids and flavonoids after oral administration of artichoke leaf extracts in humans. Phytomedicine 12:1–2 (2005), 28–38.
13. Mehmetçik, G., Özdemirler, G., Koçak-Toker, N., Çevikbaş U., Uysal, M., Effect of pretreatment with artichoke extract on carbon tetrachloride-induced liver injury and oxidative stress. Exp Toxicol Pathol 60:6 (2008), 475–480.
14. Rezazadeh, K., Aliashrafi, S., Asghari-Jafarabadi, M., Ebrahimi-Mameghani, M., Antioxidant response to artichoke leaf extract supplementation in metabolic syndrome: a double-blind placebo-controlled randomized clinical trial. Clin Nutr 37:3 (2018), 790–796.
15. Holtmann, G., Adam, B., Haag, S., Collet, W., Grünewald, E., Windeck, T., Efficacy of artichoke leaf extract in the treatment of patients with functional dyspepsia: a six-week placebo-controlled, double-blind, multicentre trial. Aliment Pharmacol Ther 18:11–12 (2003), 1099–1105.
16. Zhu, X., Zhang, H., Lo, R., Phenolic compounds from the leaf extract of artichoke (Cynara scolymus L.) and their antimicrobial activities. J Agric Food Chem 52:24 (2004), 7272–7278.
17. Rezazadeh, K., Rahmati-Yamchi, M., Mohammadnejad, L., Ebrahimi-Mameghani, M., Delazar, A., Effects of artichoke leaf extract supplementation on metabolic parameters in women with metabolic syndrome: influence of TCF7L2-rs7903146 and FTO-rs9939609 polymorphisms. Phytother Res 32:1 (2018), 84–93.
18. Rezazadeh, K., Rezazadeh, F., Ebrahimi-Mamaghani, M., The effect of artichoke leaf extract supplementation on lipid and CETP response in metabolic syndrome with respect to Taq 1B CETP polymorphism: a randomized, controlled clinical trial. Eur J Integr Med 17 (2018), 112–118.
19. Petrowicz, O., Gebhardt, R., Donner, M., Schwandt, P., Kraft, K., Effects of artichoke leaf extract (ALE) on lipoprotein metabolism in vitro and in vivo. Atherosclerosis, 1(129), 1997, 147.
20. Bundy, R., Walker, A.F., Middleton, R.W., Wallis, C., Simpson, H.C., Artichoke leaf extract (Cynara scolymus) reduces plasma cholesterol in otherwise healthy hypercholesterolemic adults: a randomized, double blind placebo controlled trial. Phytomedicine 15:9 (2008), 668–675.
21. Rondanelli, M., Opizzi, A., Faliva, M., Sala, P., Perna, S., Riva, A., et al. Metabolic management in overweight subjects with naive impaired fasting glycaemia by means of a highly standardized extract from Cynara scolymus: a double-blind, placebo-controlled, randomized clinical trial. Phytother Res 28:1 (2014), 33–41.
22. Rondanelli, M., Giacosa, A., Orsini, F., Opizzi, A., Villani, S., Appetite control and glycaemia reduction in overweight subjects treated with a combination of two highly standardized extracts from Phaseolus vulgaris and Cynara scolymus. Phytother Res 25:9 (2011), 1275–1282.
23. Zan, M.A., Ferraz, A.B., Richter, M.F., Picada, J.N., de Andrade, H.H., Lehmann, M., et al. In vivo genotoxicity evaluation of an artichoke (Cynara scolymus L.) aqueous extract. J Food Sci 78:2 (2013), T367–T371.
24. Rondanelli, M., Giacosa, A., Opizzi, A., Faliva, M.A., Sala, P., Perna, S., et al. Beneficial effects of artichoke leaf extract supplementation on increasing HDL-cholesterol in subjects with primary mild hypercholesterolaemia: a double-blind, randomized, placebo-controlled trial. Int J Food Sci Nutr 64:1 (2013), 7–15.
25. Alberti, K.G., Eckel, R.H., Grundy, S.M., Zimmet, P.Z., Cleeman, J.I., Donato, K.A., et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:16 (2009), 1640–1645.
26. Azizi, F., Hadaegh, F., Khalili, D., Esteghamati, A., Hosseinpanah, F., Delavari, A., et al. Appropriate definition of metabolic syndrome among Iranian adults: report of the Iranian National Committee of Obesity. Arch Iran Med 13:5 (2010), 426–428.
27. Ghasemi, Dehkordi N., Iranian herbal pharmacopeia. Tehran: Ministry of Health, Treatment and Medical. Education, 2002, 655–666 [Persian].
28. Committee, I.R., Guidelines for data processing and analysis of the International Physical Activity Questionnaire (IPAQ)—short and long forms. PLoS One, 17, 2005, 2008.
29. Craig, C.L., Marshall, A.L., Sjöström, M., Bauman, A.E., Booth, M.L., Ainsworth, B.E., et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 35:8 (2003), 1381–1395.
30. Friedewald, W.T., Levy, R.I., Fredrickson, D.S., Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:6 (1972), 499–502.
31. Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F., Turner, R.C., Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:7 (1985), 412–419.
32. Parra, E.J., Cameron, E., Simmonds, L., Valladares, A., McKeigue, P., Shriver, M., et al. Association of TCF7L2 polymorphisms with type 2 diabetes in Mexico City. Clin Genet 71:4 (2007), 359–366.
33. Ihaka, R., Gentleman, R., R: a language for data analysis and graphics. J Comput Graph Stat 5:3 (1996), 299–314.
34. Finniss, D.G., Kaptchuk, T.J., Miller, F., Benedetti, F., Biological, clinical, and ethical advances of placebo effects. Lancet 375:9715 (2010), 686–695.
35. Shimoda, H., Ninomiya, K., Nishida, N., Yoshino, T., Morikawa, T., Matsuda, H., et al. Anti-hyperlipidemic sesquiterpenes and new sesquiterpene glycosides from the leaves of artichoke (Cynara scolymus L.): structure requirement and mode of action. Bioorg Med Chem Lett 13:2 (2003), 223–228.
36. Küçükgergin, C., Aydın, A.F., Ozdemirler-Erata, G., Mehmetçik, G., Koçak-Toker, N., Uysal, M., Effect of artichoke leaf extract on hepatic and cardiac oxidative stress in rats fed on high cholesterol diet. Biol Trace Elem Res 135:1–3 (2010), 264–274.
37. Qiang, Z., Lee, S.O., Ye, Z., Wu, X., Hendrich, S., Artichoke extract lowered plasma cholesterol and increased fecal bile acids in Golden Syrian hamsters. Phytother Res 26:7 (2012), 1048–1052.
38. Englisch, W., Beckers, C., Unkauf, M., Ruepp, M., Zinserling, V., Efficacy of artichoke dry extract in patients with hyperlipoproteinemia. Arzneimittelforschung 50:03 (2000), 260–265.
39. Gebhardt, R., Inhibition of cholesterol biosynthesis in HepG2 cells by artichoke extracts is reinforced by glucosidase pretreatment. Phytother Res 16:4 (2002), 368–372.
40. Arion, W.J., Canfield, W.K., Ramos, F.C., Schindler, P.W., Burger, H.J., Hemmerle, H., et al. Chlorogenic acid and hydroxynitrobenzaldehyde: new inhibitors of hepatic glucose 6-phosphatase. Arch Biochem Biophys 339:2 (1997), 315–322.
41. Matsui, T., Ogunwande, I.A., Abesundara, K.J., Matsumoto, K., Anti-hyperglycemic potential of natural products. Mini Rev Med Chem 6:3 (2006), 349–356.
42. Povel, C.M., Boer, J.M., Reiling, E., Feskens, E.J., Genetic variants and the metabolic syndrome: a systematic review. Obes Rev 12:11 (2011), 952–967.
43. Lyssenko, V., Lupi, R., Marchetti, P., Del Guerra, S., Orho-Melander, M., Almgren, P., et al. Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J Clin Invest 117:8 (2007), 2155–2163.
44. Corella, D., Carrasco, P., Sorlí J.V., Estruch, R., Rico-Sanz, J., Martínez-González, M.Á., et al. Mediterranean diet reduces the adverse effect of the TCF7L2-rs7903146 polymorphism on cardiovascular risk factors and stroke incidence. Diabetes Care 36:11 (2013), 3803–3811.
45. Türkalp, I., Cil, Z., Ozkazanç D., Analytical performance of a direct assay for LDL-cholesterol: a comparative assessment versus Friedewald's formula. Anadolu Kardiyol Derg 5:1 (2005), 13–17.
46. Mora, S., Rifai, N., Buring, J.E., Ridker, P.M., Comparison of LDL cholesterol concentrations by Friedewald calculation and direct measurement in relation to cardiovascular events in 27,331 women. Clin Chem 55:5 (2009), 888–894.